| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 5/24/2022 | HLVX HilleVax | Initiated Coverage | $10.00 | $30.00 | Outperform | High |
| 5/24/2022 | MIRM Mirum Pharmaceuticals | Boost Price Target | $25.00 | $50.00 ➝ $52.00 | Outperform | Low |
| 5/23/2022 | ROIV Roivant Sciences | Initiated Coverage | $4.00 | $6.00 | Outperform | High |
| 5/23/2022 | RDUS Radius Health | Initiated Coverage | $6.00 | $7.00 | Market Perform | Medium |
| 5/23/2022 | TBPH Theravance Biopharma | Initiated Coverage | $9.00 | $12.00 | Outperform | High |
| 5/23/2022 | KDNY Chinook Therapeutics | Boost Price Target | $15.00 | $38.00 ➝ $44.00 | Outperform | High |
| 5/23/2022 | HALO Halozyme Therapeutics | Initiated Coverage | $45.00 | $52.00 | Outperform | Low |
| 5/23/2022 | PFE Pfizer | Initiated Coverage | $53.00 | $55.00 | Market Perform | Low |
| 5/23/2022 | SNY Sanofi | Initiated Coverage | $56.00 | | Outperform | Medium |
| 5/23/2022 | GILD Gilead Sciences | Initiated Coverage | $64.00 | $68.00 | Market Perform | Low |
| 5/23/2022 | HZNP Horizon Therapeutics Public | Initiated Coverage | $88.00 | $95.00 | Market Perform | High |
| 5/23/2022 | ABBV AbbVie | Initiated Coverage | $149.00 | $140.00 | Underperform | High |
| 5/23/2022 | AMGN Amgen | Initiated Coverage | $252.00 | $256.00 | Market Perform | Low |
| 5/23/2022 | VRTX Vertex Pharmaceuticals | Initiated Coverage | $268.00 | $265.00 | Market Perform | High |
| 5/23/2022 | LLY Eli Lilly and | Initiated Coverage | $306.00 | $341.00 | Outperform | Low |
| 5/23/2022 | REGN Regeneron Pharmaceuticals | Initiated Coverage | $686.00 | $738.00 | Outperform | Medium |
| 5/20/2022 | AMTI Applied Molecular Transport | Lower Price Target | $3.00 | $60.00 ➝ $21.00 | Outperform | Low |
| 5/20/2022 | RCKT Rocket Pharmaceuticals | Boost Price Target | $10.00 | $64.00 ➝ $66.00 | Outperform | High |
| 5/20/2022 | REPL Replimune Group | Lower Price Target | $14.00 | $49.00 ➝ $48.00 | Outperform | High |
| 5/19/2022 | ENTA Enanta Pharmaceuticals | Lower Price Target | $39.00 | $58.00 ➝ $44.00 | Market Perform | High |
| 5/18/2022 | LVTX LAVA Therapeutics | Boost Price Target | $3.00 | $25.00 | Outperform | Low |
| 5/17/2022 | SCPH scPharmaceuticals | Boost Price Target | $5.00 | $6.00 | Market Perform | Low |
| 5/17/2022 | AGIO Agios Pharmaceuticals | Boost Price Target | $19.00 | $33.00 | Market Perform | Medium |
| 5/17/2022 | HOLX Hologic | Boost Price Target | $78.00 | $85.00 | Outperform | Low |
| 5/12/2022 | CRBU Caribou Biosciences | Boost Price Target | $8.00 | $30.00 ➝ $34.00 | | High |
| 5/12/2022 | RXDX Prometheus Biosciences | Reiterated Rating | $28.00 | | Outperform | N/A |
| 5/11/2022 | BHVN Biohaven Pharmaceutical | Downgrade | $143.00 | $150.00 | Outperform ➝ Market Perform | Low |
| 5/10/2022 | RPHM Reneo Pharmaceuticals | Reiterated Rating | $2.00 | | Outperform | High |
| 5/10/2022 | GDRX GoodRx | Downgrade | $8.00 | $33.00 ➝ $10.00 | Outperform ➝ Market Perform | High |
| 5/9/2022 | RVMD Revolution Medicines | Reiterated Rating | $16.00 | | Outperform | High |
| 5/5/2022 | ALGS Aligos Therapeutics | Downgrade | $1.00 | | Outperform ➝ Market Perform | High |
| 5/5/2022 | AMRN Amarin | Downgrade | $1.00 | $10.00 ➝ $3.00 | Outperform ➝ Market Perform | High |
| 5/3/2022 | PINC Premier | Reiterated Rating | $37.00 | | Outperform | Low |
| 4/29/2022 | ACCD Accolade | Downgrade | $6.00 | $32.00 ➝ $8.00 | Outperform ➝ Market Perform | High |
| 4/29/2022 | DXCM DexCom | Lower Price Target | $288.00 | $565.00 ➝ $500.00 | | High |
| 4/28/2022 | MOLN Molecular Partners | Lower Price Target | $7.00 | $42.00 ➝ $29.00 | | Medium |
| 4/28/2022 | TDOC Teladoc Health | Downgrade | $31.00 | | Outperform ➝ Market Perform | High |
| 4/27/2022 | SLDB Solid Biosciences | Reiterated Rating | $0.00 | | Outperform | High |
| 4/27/2022 | LVTX LAVA Therapeutics | Reiterated Rating | $3.00 | | Outperform | Low |
| 4/26/2022 | ELYM Eliem Therapeutics | Lower Price Target | $3.00 | $33.00 ➝ $13.00 | Outperform | High |
| 4/26/2022 | OPT Opthea | Initiated Coverage | $7.00 | $25.00 | Outperform | High |
| 4/26/2022 | MIRM Mirum Pharmaceuticals | Boost Price Target | $25.00 | $46.00 ➝ $49.00 | Outperform | Medium |
| 4/25/2022 | EWTX Edgewise Therapeutics | Reiterated Rating | $6.00 | | Outperform | High |
| 4/25/2022 | HCA HCA Healthcare | Lower Price Target | $205.00 | $304.00 ➝ $273.00 | Outperform | Medium |
| 4/22/2022 | THC Tenet Healthcare | Boost Price Target | $62.00 | $100.00 ➝ $110.00 | Outperform | High |
| 4/21/2022 | APTX Aptinyx | Lower Price Target | $1.00 | $10.00 ➝ $4.00 | Outperform | Low |
| 4/21/2022 | ALKS Alkermes | Boost Price Target | $28.00 | $24.00 ➝ $25.00 | Market Perform | Low |
| 4/21/2022 | ZLAB Zai Lab | Lower Price Target | $34.00 | $102.00 ➝ $101.00 | Outperform | High |
| 4/21/2022 | ITCI Intra-Cellular Therapies | Boost Price Target | $57.00 | $65.00 ➝ $70.00 | Outperform | High |
| 4/21/2022 | MRK Merck & Co., Inc. | Lower Price Target | $95.00 | $100.00 ➝ $97.00 | Outperform | Low |
| 4/21/2022 | BIIB Biogen | Lower Price Target | $203.00 | $300.00 ➝ $270.00 | Outperform | Medium |
| 4/21/2022 | ANTM Anthem | Boost Price Target | $505.00 | $483.00 ➝ $555.00 | Market Perform | Medium |
| 4/19/2022 | UNH UnitedHealth Group | Boost Price Target | $498.00 | $550.00 ➝ $600.00 | Outperform | Low |
| 4/18/2022 | NKTR Nektar Therapeutics | Lower Price Target | $3.00 | $7.00 ➝ $6.00 | Market Perform | High |
| 4/18/2022 | TNDM Tandem Diabetes Care | Reiterated Rating | $65.00 | | Market Perform | High |
| 4/14/2022 | THC Tenet Healthcare | Reiterated Rating | $62.00 | $100.00 | Buy | N/A |
| 4/13/2022 | MYOV Myovant Sciences | Lower Price Target | $10.00 | $19.00 ➝ $12.00 | Market Perform | High |
| 4/13/2022 | MDT Medtronic | Reiterated Rating | $106.00 | | Market Perform | Medium |
| 4/12/2022 | ZNTL Zentalis Pharmaceuticals | Lower Price Target | $21.00 | $78.00 ➝ $67.00 | Outperform | High |
| 4/11/2022 | RUBY Rubius Therapeutics | Lower Price Target | $1.00 | $5.00 ➝ $3.00 | Market Perform | High |
| 4/11/2022 | GNFT Genfit | Lower Price Target | $3.00 | $15.00 ➝ $10.00 | Outperform | High |
| 4/8/2022 | ACHC Acadia Healthcare | Boost Price Target | $71.00 | $80.00 ➝ $90.00 | Outperform | High |
| 4/6/2022 | IMRA IMARA | Reiterated Rating | $1.00 | | Outperform ➝ Market Perform | Medium |
| 4/6/2022 | BLUE bluebird bio | Lower Price Target | $3.00 | $10.00 ➝ $8.00 | Market Perform | Medium |
| 4/6/2022 | MRK Merck & Co., Inc. | Lower Price Target | $95.00 | $101.00 ➝ $100.00 | Outperform | Medium |
| 4/4/2022 | CALA Calithera Biosciences | Lower Price Target | $0.00 | $3.00 ➝ $2.00 | Outperform | Medium |
| 4/4/2022 | ALHC Alignment Healthcare | Initiated Coverage | $10.00 | $19.00 | Outperform | Low |
| 4/1/2022 | MREO Mereo BioPharma Group | Reiterated Rating | $0.00 | $8.00 | Buy | Medium |
| 4/1/2022 | CNTB Connect Biopharma | Initiated Coverage | $1.00 | $22.00 | Buy | High |
| 4/1/2022 | SBTX Silverback Therapeutics | Downgrade | $3.00 | | Outperform ➝ Market Perform | High |
| 4/1/2022 | IONS Ionis Pharmaceuticals | Lower Price Target | $37.00 | $29.00 ➝ $26.00 | Market Perform | High |
| 3/31/2022 | AXLA Axcella Health | Lower Price Target | $2.00 | $10.00 ➝ $9.00 | Outperform | Medium |
| 3/31/2022 | AGL agilon health | Boost Price Target | $19.00 | $25.00 ➝ $33.00 | Outperform | High |
| 3/31/2022 | PHR Phreesia | Lower Price Target | $17.00 | $41.00 ➝ $29.00 | Market Perform | High |
| 3/30/2022 | VINC Vincerx | Lower Price Target | $2.00 | $24.00 ➝ $20.00 | Outperform | Low |
| 3/30/2022 | PHVS Pharvaris | Lower Price Target | $17.00 | $50.00 ➝ $45.00 | Outperform | Medium |
| 3/29/2022 | ACLX Arcellx | Lower Price Target | $9.00 | $47.00 ➝ $44.00 | Outperform | High |
| 3/29/2022 | NEO NeoGenomics | Lower Price Target | $8.00 | $45.00 ➝ $20.00 | Outperform | High |
| 3/25/2022 | IFRX InflaRx | Lower Price Target | $1.00 | $8.00 ➝ $6.00 | Outperform | Low |
| 3/25/2022 | ETNB 89bio | Lower Price Target | $3.00 | $62.00 ➝ $50.00 | Outperform | High |
| 3/25/2022 | PRVA Privia Health Group | Boost Price Target | $23.00 | $43.00 ➝ $44.00 | Outperform | Low |
| 3/25/2022 | MRNA Moderna | Lower Price Target | $132.00 | $81.00 ➝ $80.00 | Underperform | High |
| 3/24/2022 | RPHM Reneo Pharmaceuticals | Lower Price Target | $2.00 | $25.00 ➝ $15.00 | Outperform | Low |
| 3/24/2022 | IMTX Immatics | Lower Price Target | $7.00 | $32.00 ➝ $25.00 | Outperform | Medium |
| 3/23/2022 | ALGS Aligos Therapeutics | Lower Price Target | $1.00 | $11.00 ➝ $7.00 | Outperform | High |
| 3/22/2022 | GRPH Graphite Bio | Lower Price Target | $2.00 | $34.00 ➝ $18.00 | Outperform | High |
| 3/22/2022 | MRNS Marinus Pharmaceuticals | Lower Price Target | $5.00 | $30.00 ➝ $27.00 | Outperform | Medium |
| 3/22/2022 | CRBU Caribou Biosciences | Lower Price Target | $8.00 | $32.00 ➝ $29.00 | Outperform | High |
| 3/18/2022 | SYBX Synlogic | Lower Price Target | $1.00 | $11.00 ➝ $8.00 | Outperform | High |
| 3/18/2022 | IPSC Century Therapeutics | Reiterated Rating | $8.00 | $32.00 | Buy | High |
| 3/17/2022 | ATNX Athenex | Boost Price Target | $1.00 | $2.00 ➝ $3.00 | Market Perform | High |
| 3/17/2022 | BGNE BeiGene | Downgrade | $123.00 | $300.00 ➝ $177.00 | Outperform ➝ Market Perform | Low |
| 3/16/2022 | IMRA IMARA | Lower Price Target | $1.00 | $37.00 ➝ $31.00 | Outperform | High |
| 3/16/2022 | SPRB Spruce Biosciences | Lower Price Target | $1.00 | $5.00 ➝ $3.00 | Market Perform | High |
| 3/15/2022 | ADAP Adaptimmune Therapeutics | Lower Price Target | $1.00 | $7.00 ➝ $3.00 | Market Perform | High |
| 3/15/2022 | NKTR Nektar Therapeutics | Lower Price Target | $3.00 | $18.00 ➝ $7.00 | Market Perform | High |
| 3/15/2022 | PRDS Pardes Biosciences | Initiated Coverage | $6.00 | $18.00 | Outperform | Low |
| 3/15/2022 | AGL agilon health | Lower Price Target | $19.00 | $35.00 ➝ $25.00 | Outperform | High |
| 3/15/2022 | ASND Ascendis Pharma A/S | Boost Price Target | $90.00 | $190.00 ➝ $193.00 | Outperform | High |
| 3/15/2022 | ANTM Anthem | Boost Price Target | $505.00 | $465.00 ➝ $483.00 | Market Perform | Medium |
